INS and COVID-19: While the need for insulin is normally limited in women with GDM, it should be kept in mind that the need for insulin increases with a history of COVID-19, and dysglycemia treatment in GDM patients with a history of COVID-19 may require enhanced care in terms of blood glucose regulation.